ALNY — Recent News Coverage
All news mentioning ALNY in ESEN's AI-graded feed
News stories with ALNY as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on ALNY. See /coverage/ALNY for the 30-day aggregate.
SEEKINGALPHA.COM
·
2026-07-16
NEUTRAL
BULLISH
CORR0.42
Alnylam Pharmaceuticals: Commercial Momentum Outweighs TTR Read-Through Concerns (NASDAQ:ALNY)
$ALNY
◈ ESEN AI
Alnylam Pharmaceuticals (ALNY) is being reassessed by analysts as commercial execution and financial strength offset concerns around TTR (transthyretin) drug portfolio headwinds. The biotech firm's improved cash positio…
FINANCE.YAHOO.COM
·
2026-07-14
NEUTRAL
BULLISH
CORR0.42
Morgan Stanley Raises its Price Target on Alnylam (ALNY)
$ALNY
◈ ESEN AI
Alnylam (ALNY) has attracted multiple analyst price target increases, with Morgan Stanley raising its target to $400 from $370 while maintaining an Equal Weight rating. This divergence between higher price targets and n…
INSIDERMONKEY.COM
·
2026-07-12
NEUTRAL
BULLISH
CORR0.62
10 Best Growth Stocks With Highest Upside Potential
$ALNY
$COIN
◈ ESEN AI
BlackRock's commentary on broadening earnings strength signals a potential rotation away from concentrated Magnificent Seven dominance toward wider equity participation. The new trend of upward revisions suggests fundam…
MANILATIMES.NET
·
2026-07-06
LOW
NEUTRAL
CORR0.15
Kalaris Appoints Laurie Keating to Board of Directors
$ALNY
◈ ESEN AI
Kalaris has appointed Laurie Keating, a seasoned biotechnology executive, to its Board of Directors. This appointment signals management's intent to strengthen governance and operational oversight as the company pursues…
INSIDERMONKEY.COM
·
2026-07-02
NEUTRAL
BULLISH
CORR0.42
Komodo Expands Strategic Partnership with Alnylam Pharmaceuticals, Inc. (ALNY)
$ALNY
◈ ESEN AI
Alnylam Pharmaceuticals (ALNY) announced an expanded strategic partnership with Komodo Health on June 25, signaling deeper collaboration in commercial and data analytics capabilities. Partnership expansions typically in…
INSIDERMONKEY.COM
·
2026-06-30
LOW
NEUTRAL
CORR0.35
10 Best Fundamentally Strong Stocks to Buy for Long Term
$ALNY
$CNM
◈ ESEN AI
This article presents a curated listicle of fundamentally strong equities positioned for long-term appreciation, anchored by commentary from JPMorgan Private Bank's global investment strategy leadership. The piece frame…
SEEKINGALPHA.COM
·
2026-06-25
NEUTRAL
NEUTRAL
CORR0.15
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses ALN-6400 RNAi Therapy Targeting Plasminogen for Rare Bleeding Disorders Transcript
$ALNY
◈ ESEN AI
Alnylam Pharmaceuticals (ALNY) has disclosed details regarding its ALN-6400 RNAi therapy candidate targeting plasminogen for rare bleeding disorders. This pipeline update represents standard clinical development communi…
SEEKINGALPHA.COM
·
2026-06-25
NEUTRAL
NEUTRAL
CORR0.35
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses ALN-6400 RNAi Therapy Targeting Plasminogen for Rare Bleeding Disorders - Slideshow (NASDAQ:ALNY) 2026-06-25
$ALNY
◈ ESEN AI
Alnylam Pharmaceuticals (ALNY) presented clinical and development data on ALN-6400, an RNAi therapeutic candidate designed to target plasminogen for rare bleeding disorder indications. The disclosure appears to be a sta…
INSIDERMONKEY.COM
·
2026-06-23
LOW
BULLISH
CORR0.35
Alnylam Pharmaceuticals, Inc. (ALNY) and GENESIS Pharma Expand Commercial Partnership
$ALNY
◈ ESEN AI
Alnylam Pharmaceuticals (ALNY) announced an expansion of its commercial partnership with GENESIS Pharma to cover four Nordic markets: Denmark, Finland, Norway, and Sweden. This represents a geographic extension of an ex…
FINANCE.YAHOO.COM
·
2026-06-22
NEUTRAL
BULLISH
CORR0.45
Alnylam (ALNY) Expands Its RNAi Therapeutics Reach Into Four More Nordic Countries
$ALNY
◈ ESEN AI
Alnylam (ALNY) has extended its commercial footprint in Northern Europe through an expanded partnership with GENESIS Pharma, covering Sweden, Finland, Denmark, and Norway. This geographic expansion represents a strategi…
EXPLORE OTHER FILTERS